Cargando…
Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of bone marrow cells originating from immature myeloid cells. They exert potent immunosuppressive activity and are closely associated with the development of various diseases such as malignancies, infections, and inflammation. I...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295421/ https://www.ncbi.nlm.nih.gov/pubmed/35854339 http://dx.doi.org/10.1186/s40164-022-00296-9 |
_version_ | 1784750054889750528 |
---|---|
author | Yu, Shunjie Ren, Xiaotong Li, Lijuan |
author_facet | Yu, Shunjie Ren, Xiaotong Li, Lijuan |
author_sort | Yu, Shunjie |
collection | PubMed |
description | Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of bone marrow cells originating from immature myeloid cells. They exert potent immunosuppressive activity and are closely associated with the development of various diseases such as malignancies, infections, and inflammation. In malignant tumors, MDSCs, one of the most dominant cellular components comprising the tumor microenvironment, play a crucial role in tumor growth, drug resistance, recurrence, and immune escape. Although the role of MDSCs in solid tumors is currently being extensively studied, little is known about their role in hematologic malignancies. In this review, we comprehensively summarized and reviewed the different roles of MDSCs in hematologic malignancies and hematopoietic stem cell transplantation, and finally discussed current targeted therapeutic strategies.Affiliation: Kindly check and confirm the processed affiliations are correct. Amend if any.correct |
format | Online Article Text |
id | pubmed-9295421 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92954212022-07-20 Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin Yu, Shunjie Ren, Xiaotong Li, Lijuan Exp Hematol Oncol Review Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of bone marrow cells originating from immature myeloid cells. They exert potent immunosuppressive activity and are closely associated with the development of various diseases such as malignancies, infections, and inflammation. In malignant tumors, MDSCs, one of the most dominant cellular components comprising the tumor microenvironment, play a crucial role in tumor growth, drug resistance, recurrence, and immune escape. Although the role of MDSCs in solid tumors is currently being extensively studied, little is known about their role in hematologic malignancies. In this review, we comprehensively summarized and reviewed the different roles of MDSCs in hematologic malignancies and hematopoietic stem cell transplantation, and finally discussed current targeted therapeutic strategies.Affiliation: Kindly check and confirm the processed affiliations are correct. Amend if any.correct BioMed Central 2022-07-19 /pmc/articles/PMC9295421/ /pubmed/35854339 http://dx.doi.org/10.1186/s40164-022-00296-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Yu, Shunjie Ren, Xiaotong Li, Lijuan Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin |
title | Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin |
title_full | Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin |
title_fullStr | Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin |
title_full_unstemmed | Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin |
title_short | Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin |
title_sort | myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295421/ https://www.ncbi.nlm.nih.gov/pubmed/35854339 http://dx.doi.org/10.1186/s40164-022-00296-9 |
work_keys_str_mv | AT yushunjie myeloidderivedsuppressorcellsinhematologicmalignanciestwosidesofthesamecoin AT renxiaotong myeloidderivedsuppressorcellsinhematologicmalignanciestwosidesofthesamecoin AT lilijuan myeloidderivedsuppressorcellsinhematologicmalignanciestwosidesofthesamecoin |